activity and gene of its bifunctional aminoglycoside-modifying enzyme, AAC(6')/APH(2"), in comparison with those of a regular one that has been known as the critical resistance basis to both gentamicin and arbekacin in methicillin-resistant Staphylococcus aureus. The aac(6')/aph(2") gene of strain PRC104 contained a single base alteration at a novel site (G 1126A) resulting in one amino acid substitution (S376N) in the phosphorylation catalytic motif. The phosphorylation activity of the PRC104 enzyme was enhanced for arbekacin and reduced for gentamicin. Both strain PRC104 and S. aureus RN4220 containing the cloned gene were identical in terms of the substrate specificity of the enzyme as well as the aminoglycoside resistance profile, although both mRNA and aminoglycoside resistance levels were markedly high in strain PRC104. Therefore, the cloned aac(6')/aph(2") gene may represent the molecular basis for the novel aminoglycoside modification capability as well as novel aminoglycoside resistance profile of S. aureus PRC104.
Methicillin-resistant Staphylococcus aureus (MRSA) has been and still is one of the most serious microorganisms in the nosocomial infection problem in Japan, because of relatively high incidence of MRSA strains with multiple resistance to wide varieties of antibiotics1,2). Therefore, a limited number of antibiotics are available as anti-MRSA drugs such as vancomycin (VCM) and teicoplanin. In addition, arbekacin (ABK), a semisynthetic aminoglycoside (AG) antibiotic, has also been used as the anti-MRSA orphan drug in Japan since 19903).
These antibiotics still keep good anti-MRSA activity clinically1,2). In other words, incidence of MRSA isolates with resistance to these antibiotics still remains very low.
Actually, neither distinct VCM-resistant MRSA (VRSA) such as the one emerged in US4) nor incidence increase of ABK-resistant MRSA has been reported1,2). Concerning ABK, MRSA strains with low level ABK resistance emerged soon after ABK was introduced into clinics5).
Subsequent analysis of the ABK resistance revealed a bifunctional AG-modifying enzyme, AAC(6')/APH(2") as the critical factor to ABK resistance. This enzyme has been known to play important roles in the multiple AG resistance of MRSA since it confers its host organisms with the capability of 6'-N-acetylation and/or 2"-O-phosphorylation of AGs that contain 6'-NH2 and/or 2"-OH as shown in 11,9,10). An additional novel characteristic that might assist ABK to resist inactivation by AAC(6')/APH(2") is that the acetylation products of ABK by AAC(3), AAC(2') and AAC(6') retained antibiotic activities, while those of GM were inactive except for the acetylated GM by AAC(6') as
Recently, an exceptional MRSA strain with novel AG resistance profile was isolated12). The strain showed high compared with the resistance profile of the dominant type MRSA isolates in Japanese hospitals which are so called NY/Japan type ones13). They usually show coagulase serotype II and at least 16-32 fold higher resistance to GM than to ABK when they contain the aac(6')/aph(2") gene.
In this study, we characterize the activity and gene of AAC(6')/APH(2") of strain PRC104 and demonstrate a single base alteration in the APH(2") region of aac(6')/aph(2") gene that resulted in a novel substrate specificity of the enzyme.
Materials and Methods

Bacterial Strains and Culture Conditions
The bacterial strains and plasmids are described in Table   1 . S. aureus strains were grown in Brain Heart Infusion (BHI; Difco Lab. ML) with shaking or on BHI agar plates primers were synthesized by Sigma genosis (Japan). Plasmid pAW8 containing aac(6')aph(2") was constructed as follows; a 2.0kb fragment spanning aac(6')aph(2") gene was amplified by PCR using KOD-plus-DNA polymerase (TOYOBO, Japan) and the following two primers, each containing BamHI sites (5'-TATTGGATCCGTTCTTATGGACCTACAT 3' and 5'-TTCTGGATCCATATATTATATAATCAATC-3'). Subsequently the fragment was ligated to the BamHI site of with S. aureus RN422014) cells which were suspended in Electroporation was carried out with an electric pulse of 600 (BTX Inc. CA). The cells were then transferred into kanamycin. The transformants RN4220/w19 and RN4220/w25 contained regular aac(2')/aph(2") genes from strain BG0021. The transformants RN4220/m33 and RN4220/m47 contained a novel aac(2')/aph(2") genes from strain PRC104.
DNA Sequencing
The DNA fragments for sequencing were amplified by PCR using genomic DNA as template and purified with a PCR purification kit (Roche, Germany). The PCR products were directly sequenced with a DYEnamic ET Terminator sequencing kit (Amersham Bioscience, Corp. NJ) using a synthetic primer. The sequence was read with ABI PRISM 310 Genetic Analyzer (Applied Biosystems Japan Ltd., plotted for each primer set with critical threshold cycle values obtained from the amplification of known quantity of DNA isolated from PRC104. The quantity of aac(6')/aph(2") cDNA was normalized to that of 16SrRNA cDNA in each strain. Each RNA sample was tested in duplicate. The forward and reverse primers for aac(6')/aph(2") were 5'-TACAGAGCCTTGGGAAGATG-3' and 5'-CATTTGTGGCATTATCATCATATC-3', and those for 16SrRNA were 5'-GGATTAGATACCCTG-GTAGTC-3' and 5'-AGGGTTGCGCTCGTTG-3', respectively.
Results
Aminoglycoside (AG) Resistance of Strain PRC104
AG resistance profiles of strain PRC104 with unusually high ABK resistance and strain BG0021 with regular ABK resistance were shown in Table 2 . The resistance (MIC) to PCR typing demonstrated that these strains carried bifunctional AG-modifying enzyme (AME) gene aac(6')/aph(2"). In addition, strain PRC104 carried aad (9) and aph(3') genes and strain BG0021 carried aad(9) and aad(4',4") though data were not shown. As represented by strain BG0021, MRSA isolates with AAC(6')/APH(2") gene usually show weak or low resistance to ABK, but distinctive resistance to GM and the other AGs. Usually, GM resistance level is 16-32 fold higher than ABKresistance level. In this regard, strain PRC104 is exceptional because of its similar levels of resistance to both ABK and GM.
AG resistance profiles of S. aureus RN4220 clones transformed with aac(6')/aph(2") genes from strains PRC104 and BG0021 were also shown in Table 2 . The transformants S. aureus RN4220/m33 and RN4220/m47
(hereafter m33 and m47, respectively) showed the same AG resistance profile as that of strain PRC104, although their resistance levels were distinctively lower (16-64 fold)
except for KM resistance. Their resistance profile was, on the other hand, distinct from that of the other transformants S. aureus RN4220/w19 and RN4220/w25 (hereafter w19 and w25, respectively) containing regular type aac(6')/aph(2"). The transformants w19 and w25 showed similar AG resistance to that of strain BG0021, except for Table 2 . Aminoglycoside resistance of MRSA isolates and S. aureus RN4220 with the cloned novel aac(6')/aph(2").
Strains RN4220/w33 and RN4220/w47 contain the cloned novel aac(6')aph(2") VOL. 57 NO. 10 THE JOURNAL OF ANTIBIOTICS 683 resistance to AMK and ISP. This should be due to that w19 and w25 lack aad(4', 4") that may inactivate both AMK and ISP by modifying their 4'-OH.
Alteration Detected in aac(6')/aph(2") Cloned from Strain PRC104
Nucleotide sequencing revealed that the coding region of aac(6')/aph(2") from PRC104 contained a single nucleotide alteration (G1126A) resulting in S376N substitution at a unique position in the highly conserved catalytic domain for 2"-O-phosphorylation (Fig. 2) . Additionally, aph(3') was also sequenced but no alteration was detected.
AG Modification Activity of Strain PRC104 and Transformants
Activities of acetylation and phosphorylation of ABK and GM were examined with cell free extracts (CFEs) from strain PRC104 and w19 as shown in Fig. 3A . It turned out that strain PRC104 showed a markedly higher ABK phosphorylating activity and a distinctly lower GM phosphorylating activity, compared with those of the strain w19. Structure determination of the phosphorylated ABK by NMR analysis indicated that all of the NMR signals were identical with those of authentic 2"-O-phosphorylated ABK. Fig. 3B shows phosphorylation of ABK and GM using CFEs from strains w19 and w25 containing the regular type AAC(6')/APH(2") as well as strains m33 and m47 containing the novel S376N variant enzyme. ABK phosphorylation was markedly faster with CFEs from strains m33 and m47 than with those from strains w19 and w25. In contrast, the phosphorylation of GM was faster with CFEs from strains w19 and w25. These results were closely similar to those obtained with CFE from strain PRC104. The acetylation of ABK and GM was faster with CFEs from strains w19 and w25 (data not shown). It was notable that the ABK reaction mixtures retained weak but distinct antibiotic activity even after complete acetylation.
mRNA Level of aac(6')/aph(2") in PRC104 Fig. 4A shows Northern blot analysis results. The mRNA level of aac(6')/aph(2") was markedly higher in strain PRC104 than in the other strains (w19, w25, m33 and m47) that contained the cloned aac(6')/aph(2") genes. In the real time RT-PCR (Fig. 4B) , it was confirmed that aac(6')/aph(2") mRNA level from PRC104 was about 5 folds higher than those of the other strains. No substantial difference in the mRNA level of aac(6')/aph(2") was observed among the strains other than strain PRC104. It was thus obvious that high level expression of the novel type aac(6')/aph(2") gene in strain PRC104 markedly high AG resistance.
Discussion
Compared to known clinical MRSA strains with AG resistance, strain PRC104 is unusual because of its unusually high level of ABK resistance comparable to that of GM resistance.
Since aac(6')/aph(2") has been known as the sole (Fig. 3) . (A) TLC after acetylation or phosphorylation reaction for 30 minutes with CFEs (Lanes 1, 2 and 3 refer to 0, phosphorylation reaction (1 hour) of ABK or GM with CFEs prepared from strains containing regular or novel types of AAC(6')/APH(2").
Lanes 1, 2, 3, 4 and 5 refer to cell free extracts prepared from RN4220 clones containing pAW8, w19, w25, m33, and m47, respectively. Lane 6 refers to CFE from strain PRC104. Fig. 4 . aac(6')/aph(2") mRNA levels in RN4220 transformants and PRC104.
(A) Northern blotting: Lanes 1, 2, 3. 4 and 5 refer to total RNA prepared from RN4220 clones containing pAW8, w19, w25, m33, and m47, respectively. Lane 6 refers to total RNA from strain PRC104. (B) Relative aac(6')/aph(2") mRNA level to that of 16S rRNA mRNA. Each bar designates the means of duplicate samples.
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The cloned gene conferred upon S. aureus RN4220 a resistance profile similar to that of strain PRC104 and CFEs from both organisms contained enzyme activities with similar substrate specificity in AG phosphorylation. i.e. higher phosphorylationion of ABK and lower phosphorylation of GM compared with the corresponding activities of strains harbouring the regular aac(6')/aph(2") gene. These results indicate that the cloned gene may be responsible for the AG resistance of strain PRC104, although the AG resistance levels of S. aureus RN4220 containing the cloned gene were markedly lower than those of strain PRC104. This was apparently due to enhanced expression of aac(6')/aph(2") in PRC104. Thus, when aac(6')/aph(2") mRNA levels in the two organisms were compared, the level was markedly higher in PRC104 than in S. aureus RN4220 containing the cloned gene, although no difference at the nucleotide level was found in the promoter or upstream region of the respective genes. Nor was there any increase in the copy of the gene in PRC104. Therefore, the underlying factor for enhancing the expression of aac(6')/aph(2") gene in strain PRC104 remains to be resolved. There are reports on plasmids containing aac(6')/aph(2") that attribute increased ABK resistance to overproduction of AAC(6')/APH(2"), although the highest MIC value that a 12 by deletion in the 5'-upstream region of the aac(6')/aph(2") structural gene produced a strong promoter activity to overexpress the gene15). However, the deduced structure of the encoded product remained unchanged. This illuminates the uniqueness of the AAC(6')/APH(2") enzyme of strain PRC104 in which a specific change in the phosphorylation catalytic domain was found.
The substrate specificity of AG modifying enzymes has also been studied, based on mutagenesis. LEE et al.16) showed that enhanced levels of AG resistance resulted from single base mutations of H258L and F108L in APH(2")-Ic. 
